A year after Mark Zuckerberg installed Alexandr Wang to jolt Meta’s artificial intelligence efforts into wartime mode, the $1.5 trillion company has produced Muse Spark, its most credible AI model yet. By handing responsibility for Meta’s AI revival to a then-28-year-old start-up founder rather than a veteran researcher, Zuckerberg bet that an outsider’s urgency and ambition could succeed where th...
A year after Mark Zuckerberg installed Alexandr Wang to jolt Meta’s artificial intelligence efforts into wartime mode, the $1.5 trillion company has produced Muse Spark, its most credible AI model yet. By handing responsibility for Meta’s AI revival to a then-28-year-old start-up founder rather than a veteran researcher, Zuckerberg bet that an outsider’s urgency and ambition could succeed where the company’s established AI organization had struggled. According to interviews with current and former Meta employees, and associates of Wang, the billionaire wunderkind has now begun to eke out results, while navigating criticism over his experience, early research challenges, and the esoteric internal politics of working at a Big Tech behemoth. Read full article Comments
When the Lebanese militia Hezbollah entered the US-Israeli war against Iran by firing rockets and drones into Israel the day after the conflict began on Feb. 28, officials there saw in the crisis sweeping the region a chance to finally drive the militia, already weakened by a series of setbacks, away from Israel’s northern border. They’ve been loath to give it up. After the US and Iran agreed to a...
When the Lebanese militia Hezbollah entered the US-Israeli war against Iran by firing rockets and drones into Israel the day after the conflict began on Feb. 28, officials there saw in the crisis sweeping the region a chance to finally drive the militia, already weakened by a series of setbacks, away from Israel’s northern border. They’ve been loath to give it up. After the US and Iran agreed to a ceasefire on April 7, Israel escalated its campaign against the Iran-backed Hezbollah. Ten days later, Israel and Lebanon agreed to their own ceasefire, but Hezbollah was not a party to it and fighting has continued sporadically. After Israel again accelerated its attacks on Lebanon in late May, Iran threatened to suspend talks aimed at an interim deal with the US to end their war. After speaking to both sides, US President Donald Trump said that Israel and Hezbollah had agreed to stop firing on one another. Israeli Prime Minister Benjamin Netanyahu said Israel would “continue to operate” in southern Lebanon” and would refrain from striking Beirut if Hezbollah stops firing on Israeli cities. What is Hezbollah? Shiite Muslims in Lebanon formed what would become Hezbollah — “party of God” — in 1982, a reaction to Israel’s occupation of the country’s south, which at the time was meant to prevent attacks on Israel from Palestinian fighters. The militia’s founding was inspired by the Islamic Revolution in Shiite-majority Iran three years earlier, and Hezbollah would be guided by Iran’s elite Islamic Revolutionary Guard Corps. Shiite and Sunni Muslims each comprise about 30% of Lebanon’s population. Hezbollah is thought to have been behind a number of major attacks on US targets in the 1980s and is designated a terrorist organization by the US , several Western countries, and the Arab states that belong to the Gulf Cooperation Council . Hezbollah guerrilla attacks contributed to Israel’s decision to withdraw in 2000 from the so-called “security zone” it had established in southe...
iQoncept/iStock via Getty Images Short interest data from late May indicates varying investor feelings in the healthcare sector, with strong bearish bets concentrated on speculative biotech plays like Recursion Pharmaceuticals ( RXRX ) and Hims & Hers ( HIMS ). Meanwhile, defensive pharma titans such as Eli Lilly ( LLY ) and Johnson & Johnson ( JNJ ) maintain minimal short positions. The healthcar...
iQoncept/iStock via Getty Images Short interest data from late May indicates varying investor feelings in the healthcare sector, with strong bearish bets concentrated on speculative biotech plays like Recursion Pharmaceuticals ( RXRX ) and Hims & Hers ( HIMS ). Meanwhile, defensive pharma titans such as Eli Lilly ( LLY ) and Johnson & Johnson ( JNJ ) maintain minimal short positions. The healthcare sector remains a notable laggard in 2026. Despite an 11.17% year-to-date rally in the S&P 500, the Health Care Select Sector SPDR® Fund ( XLV ) has moved in the opposite direction, posting a 5.43% decline despite its substantial 12.1% weighting in the benchmark. Here are the top 5 most shorted mid- to mega-cap healthcare stocks (as a % of shares outstanding) as of May 31, 2026: Recursion Pharmaceuticals ( RXRX ) – Biotechnology | Short Interest: 35.15% Hims & Hers Health ( HIMS ) – Health Care Services | Short Interest: 28.41% CRISPR Therapeutics ( CRSP ) – Biotechnology | Short Interest: 28.30% Beam Therapeutics ( BEAM ) – Biotechnology | Short Interest: 26.64% Twist Bioscience Corporation ( TWST ) – Biotechnology | Short Interest: 26.62% Conversely, investors have steered clear of betting against established industry titans and specialized medical plays. Here are the five least shorted mid- to mega-cap healthcare stocks (as a % of shares outstanding) as of May 31, 2026: Bausch + Lomb Corporation ( BLCO ) – Health Care Supplies | Short Interest: 0.70% Pharvaris N.V. ( PHVS ) – Pharmaceuticals | Short Interest: 0.86% BeOne Medicines ( ONC ) – Biotechnology | Short Interest: 0.94% Eli Lilly and Company ( LLY ) – Pharmaceuticals | Short Interest: 0.95% Johnson & Johnson ( JNJ ) – Pharmaceuticals | Short Interest: 0.96% Health Care ETFs: ( XLV ), ( VHT ), ( IHI ), ( IXJ ), ( IYH ), ( FHLC ), ( XPH ), ( PPH ), ( IBB ), ( IHE ), ( IBBQ ) and ( FXH ). More on the healthcare sector: BeOne Medicines AG (ONC) Discusses Solid Tumor Portfolio Progress and R&D Pipeline Strategy at AS...
coldsnowstorm The stocks with the highest short interest come from a broad mix within the consumer staples sector, with Packaged Foods and Meats domin ating the list in terms of positioning, according to May-end figures. Among the most shorted stocks, Freshpet ( FRPT ) leads with 19.78% of shares outstanding sold short, signaling elevated skepticism around demand trends. Other of the most shorted ...
coldsnowstorm The stocks with the highest short interest come from a broad mix within the consumer staples sector, with Packaged Foods and Meats domin ating the list in terms of positioning, according to May-end figures. Among the most shorted stocks, Freshpet ( FRPT ) leads with 19.78% of shares outstanding sold short, signaling elevated skepticism around demand trends. Other of the most shorted names include Campbell's Company ( CPB ) and e.l.f. Beauty with short percentages at 16.89% and 14.99%, respectively. In contrast, the least shorted names reflect strong investor confidence and perceived stability. These least shorted, famous names remain among the most defensively positioned. High market cap names that keep a hold on the least shorted list, including Walmart ( WMT ), Coca-Cola ( KO ), Philip Morris ( PM ), and others. Here are the five most shorted consumer staple stocks with market capitalizations above $2B (as a percentage of shares outstanding): Freshpet ( FRPT ), Short interest: 19.78% The Campbell’s Company ( CPB ), Short interest: 16.89% e.l.f. Beauty ( ELF ), Short interest: 14.99% Post Holdings ( POST ), Short interest: 13.86% Kimberly-Clark ( KMB ), Short interest: 12.74% Here are the five least shorted consumer staple stocks with market capitalizations above $2B (as a percentage of shares outstanding): Smithfield Foods ( SFD ), Short interest: 0.83% Walmart ( WMT ), Short interest: 1.03% The Coca-Cola Company ( KO ), Short interest: 1.12% Philip Morris ( PM ), Short interest: 1.13% Procter & Gamble ( PG ), Short interest: 1.26% More on Freshpet, Campbell’s Company, etc. The Procter & Gamble Company (PG) Presents at 23rd annual dbAccess Global Consumer Conference Transcript The Campbell's Company: Dividend Is Solid, Growth Is Not Walmart Earnings Summary: Stock Testing 200-Day Moving Average After Earnings These 10 large and mega-cap U.S. consumer staples firms rank among the sector's least attractively valued stocks These 10 mid-cap U.S. consumer...
IREN secured a transmission connection agreement for an 800MW data center campus in Bundey, South Australia, marking its first Australian AI infrastructure project with energization expected from 2028.
IREN secured a transmission connection agreement for an 800MW data center campus in Bundey, South Australia, marking its first Australian AI infrastructure project with energization expected from 2028.
Zeta Global (NYSE: ZETA) is building momentum with Athena, enterprise customer growth, and the Marigold acquisition, but the stock already reflects major optimism. The upside thesis depends on whether AI engagement can become real monetization, stronger margins, and deeper custom
Zeta Global (NYSE: ZETA) is building momentum with Athena, enterprise customer growth, and the Marigold acquisition, but the stock already reflects major optimism. The upside thesis depends on whether AI engagement can become real monetization, stronger margins, and deeper custom
OSI Systems ( OSIS ) announced on Wednesday that its Optoelectronics and Manufacturing unit received a $10M order from a semiconductor equipment OEM. The order covers the supply of optical sub-assemblies used in semiconductor equipment. The company said the award highlights its engineering, manufacturing, and supply chain capabilities and supports its long-term relationship with the customer. Sour...
OSI Systems ( OSIS ) announced on Wednesday that its Optoelectronics and Manufacturing unit received a $10M order from a semiconductor equipment OEM. The order covers the supply of optical sub-assemblies used in semiconductor equipment. The company said the award highlights its engineering, manufacturing, and supply chain capabilities and supports its long-term relationship with the customer. Source: Press Release More on OSI Systems OSI Systems Q3 Earnings: A Slowdown In Operations Spooked Investors; Patience Is Advised OSI Systems, Inc. (OSIS) Presents at Bank of America 33rd Annual Industrials, Transportation and Airlines Key Leaders Conference Transcript OSI Systems, Inc. (OSIS) Q3 2026 Earnings Call Transcript OSI Systems secures $15M U.S. Government task order OSI Systems ticks lower amid short pitch at Sohn Conference
Andrii Iemelyanenko/iStock via Getty Images Investment Overview: Selloff On Yesterday's Data Drop - Background To The Data Shared The stock of Minneapolis-headquartered Celcuity Inc. ( CELC ) dropped by >25% in trading yesterday after the company reported data from its Phase 3 VIKTORIA-1 study, involving its lead drug candidate, gedatolisib, in combination with fulvestrant ± palbociclib vs. standa...
Andrii Iemelyanenko/iStock via Getty Images Investment Overview: Selloff On Yesterday's Data Drop - Background To The Data Shared The stock of Minneapolis-headquartered Celcuity Inc. ( CELC ) dropped by >25% in trading yesterday after the company reported data from its Phase 3 VIKTORIA-1 study, involving its lead drug candidate, gedatolisib, in combination with fulvestrant ± palbociclib vs. standard of care ("SoC") in HR+/HER2/- PIK3CA-mutant advanced breast cancer. Before we discuss that data, for a more detailed overview of how Celcuity stock has gained a sensational >750% in value across the past 12 months, I'd refer readers to my previous note on the company for Seeking Alpha, from December last year. Put very simply, gedatolisib has shared some compelling data in advanced breast cancer, with a safety and efficacy profile established that may set the drug up to become a future standard of care in this market, in first and second line settings, and potentially prostate cancer also. Celcuity explains more in its Q1 2026 quarterly report / 10-Q filing , as follows: Our lead therapeutic candidate is gedatolisib, a kinase inhibitor of the PI3K/AKT/mTOR (“PAM”) pathway that binds to all class I PI3K isoforms and the mTOR complexes, mTORC1 and mTORC2. By targeting all class I PI3K isoforms and mTORC1/2, gedatolisib induces comprehensive inhibition of the PAM pathway. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3Kα, AKT, or mTORC1 alone or together. Our Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- ABC, has reported detailed results for Study 1, which evaluated patients with PIK3CA WT tumors, and announced topline results for Study 2, which evaluated patients with PIK3CA MT tumors. Our Phase 3 clinical trial, VIKTORIA-2, is ongoing and incorporates two independent studi...
XRP (CRYPTO: XRP) has had a rough start to June. has had a rough start to June. The cryptocurrency closed May at $1.33, dropped to $1.29 on June 1, fell further to $1.21 yesterday, and is now trading at $1.24 right now. That’s a 7% slide in three days, with $8 billion shed from XRP’s ... XRP Price Prediction for June 2026
XRP (CRYPTO: XRP) has had a rough start to June. has had a rough start to June. The cryptocurrency closed May at $1.33, dropped to $1.29 on June 1, fell further to $1.21 yesterday, and is now trading at $1.24 right now. That’s a 7% slide in three days, with $8 billion shed from XRP’s ... XRP Price Prediction for June 2026
Canada's composite purchasing managers' index (PMI) rose to 50.8 in May, up from the prior month's reading of 49.9, signaling a return to expansionary territory for the economy. Canada's services purchasing managers' index climbed to 50.6 in May, up from the prior month's reading of 49.2. farres tariq/iStock via Getty Images More on Canada, Canada’s economy: the parrot has croaked Canada Q1 GDP un...
Canada's composite purchasing managers' index (PMI) rose to 50.8 in May, up from the prior month's reading of 49.9, signaling a return to expansionary territory for the economy. Canada's services purchasing managers' index climbed to 50.6 in May, up from the prior month's reading of 49.2. farres tariq/iStock via Getty Images More on Canada, Canada’s economy: the parrot has croaked Canada Q1 GDP unexpectedly flat at 0% Q/Q, missing growth forecasts Seeking Alpha’s Quant Rating on Franklin FTSE Canada ETF Dividend scorecard for Franklin FTSE Canada ETF
Citron Research Founder Andrew Left Convicted On 17 Counts Of Securities Fraud Involving NASDAQ: NVDA, NASDAQ: TSLA And NASDAQ: META foreignpolicyjournal.com
Citron Research Founder Andrew Left Convicted On 17 Counts Of Securities Fraud Involving NASDAQ: NVDA, NASDAQ: TSLA And NASDAQ: META foreignpolicyjournal.com
The VanEck Semiconductor ETF (NASDAQ: SMH) surged 18.2% in May according to data from S&P Global Market Intelligence . It's a remarkable move for an ETF, given that ETFs' usual role is to trade off outperformance for the security of being tied to sectorwide movement. However, in this case it was sectorwide movement that produced the exceptional results. No prizes for guessing it comes down to acce...
The VanEck Semiconductor ETF (NASDAQ: SMH) surged 18.2% in May according to data from S&P Global Market Intelligence . It's a remarkable move for an ETF, given that ETFs' usual role is to trade off outperformance for the security of being tied to sectorwide movement. However, in this case it was sectorwide movement that produced the exceptional results. No prizes for guessing it comes down to accelerating momentum in artificial intelligence ( AI ) spending, with a host of companies either confirming that spending conditions remain robust or committing more capital to AI. However, a star prize is awarded for noting a subtle shift in which stocks are favored right now: broadly speaking, it's a shift from graphics processing units (GPUs) toward more traditional central processing units (CPUs). All four companies below are among the 25 holdings in the Van Eck ETF. It's worth noting that the predominantly CPU companies, Intel and Qualcomm , notably outperformed the GPU leader, Nvidia . Meanwhile, Advanced Micro Devices offers both GPUs and CPUs. Continue reading